Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Neomatrix Wound Matrix Collagen Dressing

Research Leaders

5 sponsors active, led by Federico II University

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed3

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT06271993Not ApplicableCompletedPrimary

SPT for Sensitization of Collagen Dressing

NCT03861910Completed

Dietary Choice for the Management of Cow's Milk Allergy Influences Other Allergic Manifestations

NCT03522675Not ApplicableCompletedPrimary

NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test

Showing all 3 trials

Research Network

Common Treatments

  • Neomatrix Wound Matrix Collagen Dressing1
  • Hypoallergenic Formulas1
  • Colactiveplus Collagen Matrix Dressing1

Active Sponsors

  • Federico II University1
  • NeXtGen Biologics, Inc.1
  • ALS Beauty and Personal Care1
  • Covalon Technologies Inc.1
  • State University of New York at Buffalo1

Top Investigators

Related Conditions

  • Dermatitis Allergic Contact1
  • Allergic Asthma1
  • Allergy1
  • Allergic Skin Reaction1
  • Allergy Milk1

Activity Timeline